Not Tagged
Not Tagged
['bestcli']
impressive and robust results favoring surgery &gt; endo: 10% arr and 32% rrr for death+male at 2.7 years for clti patients with available ssgsv - no meaningful difference in qol. the effect size is enormous! #bestcli #aha2022 
@BrighamSurgery Resident | @NIH Harvard-Longwood Vasc Surg T32 + @CSPH_BWH Research Fellow | @HarvardChanSPH MPH Student | @KeckMedUSC MD | @UofMaryland Alum